Farletuzumab MMAE
Product Specifications
Bioactivity
Farletuzumab-MMAE, an antibody-drug conjugate (ADC), combines an FRA-targeted antibody with Monomethyl auristatin E (MMAE) and is utilized in researching non-small cell lung cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041786-500 1x 500 µL
P63 (Squamous, Basal and Myoepithelial Cell Marker) (TP63/1786), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
